Cargando…

Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic: A review

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), puts a heavy strain on healthcare systems around the globe with high numbers of infected patients. Pre-existing cardiovascular disease is a major risk factor for a severe cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burger, Achim Leo, Kaufmann, Christoph C., Jäger, Bernhard, Pogran, Edita, Ahmed, Amro, Wojta, Johann, Farhan, Serdar, Huber, Kurt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527966/ https://www.ncbi.nlm.nih.gov/pubmed/34671829 http://dx.doi.org/10.1007/s00508-021-01956-2

Ejemplares similares

New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease
por: Burger, Achim Leo, et al.
Publicado: (2022)

Biomarkers Associated with Cardiovascular Disease in COVID-19
por: Kaufmann, Christoph C., et al.
Publicado: (2022)

Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19
por: Kaufmann, Christoph C., et al.
Publicado: (2023)

The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome
por: Pogran, Edita, et al.
Publicado: (2023)

Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review
por: Cryer, Michael Joseph, et al.
Publicado: (2022)

Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin
por: Kaufmann, Christoph C., et al.
Publicado: (2021)

Changes in Circulating Extracellular Vesicles in Patients with ST-Elevation Myocardial Infarction and Potential Effects of Remote Ischemic Conditioning—A Randomized Controlled Trial
por: Haller, Paul M., et al.
Publicado: (2020)

Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization: A real world experience
por: Rohla, Miklos, et al.
Publicado: (2016)

Mechanical complications after STEMI: Another collateral damage of the COVID-19 pandemic
por: Holzknecht, Magdalena, et al.
Publicado: (2022)

G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease
por: Katsaros, Katharina M., et al.
Publicado: (2015)

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
por: Muthspiel, Marie, et al.
Publicado: (2022)

Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
por: Jäger, Bernhard, et al.
Publicado: (2018)

Psychocardiological assessment in the acute phase of the takotsubo syndrome: Somatic and depressive disorders, resilience and illness perception
por: Weihs, Valerie, et al.
Publicado: (2021)

Cardiovascular Collateral Damages at the Time of COVID-19
por: Jacques, Frédéric, et al.
Publicado: (2020)

The Paradigm Change of IL-33 in Vascular Biology
por: Demyanets, Svitlana, et al.
Publicado: (2021)

Preventing collateral damage
por: Quon, Harry, et al.
Publicado: (2021)

Forestalling collateral damage
por: Samaranayake, L.
Publicado: (2022)

Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction
por: Hohensinner, Philipp J., et al.
Publicado: (2017)

Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Collateral cardiovascular damage during the COVID-19 pandemic
por: Nadarajah, Ramesh, et al.
Publicado: (2021)

Corona Collateral Damage Syndrome: Perception of the Damage
por: Ahmed, Asif
Publicado: (2021)

Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease
por: Ge, Peicong, et al.
Publicado: (2020)

Red Cell Distribution Width Upon Hospital Admission Predicts Short-Term Mortality in Hospitalized Patients With COVID-19: A Single-Center Experience
por: Kaufmann, Christoph C., et al.
Publicado: (2021)

Collateral damage and CRISPR genome editing
por: Thomas, Mark, et al.
Publicado: (2019)

COVID-19-induced collateral damage
Publicado: (2020)

Immune-mediated viral clearance from the CNS without collateral damage
por: Konradt, Christoph, et al.
Publicado: (2015)

Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia
por: Adikari, Dona H., et al.
Publicado: (2020)

Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1α, tumour necrosis factor-α and transforming growth factor-β
por: Jarai, Rudolf, et al.
Publicado: (2009)

Systemic Viral Infections and Collateral Damage in the Liver
por: Adams, David H., et al.
Publicado: (2006)

Tobacco control and the collateral damage of conflict of interest
por: Todkill, Anne Marie
Publicado: (2010)

Immune Activation and Collateral Damage in AIDS Pathogenesis
por: Miedema, Frank, et al.
Publicado: (2013)

An unusual collateral damage of COVID-19 pandemic
por: Medas, Renato, et al.
Publicado: (2020)

“Anosmia” the mysterious collateral damage of COVID-19
por: Ahmed, Abdulrahman K., et al.
Publicado: (2022)

Cancer screening: the collateral damage of the pandemic in Egypt
por: Eldaly, Abdullah S.
Publicado: (2021)

Collateral Damage: Gun Violence-Induced STEMI
por: Shah, Nimish N., et al.
Publicado: (2021)

Medical education-collateral damage of COVID-19?
por: Ding, Anni
Publicado: (2020)

Neutrophile-Lymphocyte Ratio and Outcome in Takotsubo Syndrome
por: Zweiker, David, et al.
Publicado: (2022)

Cerebro-/Cardiovascular Collateral Damage During the COVID-19 Pandemic: Fact or Fiction?
por: Katsouras, Christos S, et al.
Publicado: (2023)

The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro
por: Kastl, Stefan P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sh0sddbo2d5m9s87i6m2gdd4tj